These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2049553

  • 1. Clonogenic leukemic progenitor cells in acute myelocytic leukemia are highly sensitive to cryopreservation: possible purging effect for autologous bone marrow transplantation.
    Allieri MA, Lopez M, Douáy L, Mary JY, NGuyen L, Gorin NC.
    Bone Marrow Transplant; 1991 Feb; 7(2):101-5. PubMed ID: 2049553
    [Abstract] [Full Text] [Related]

  • 2. Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow.
    Zaheer HA, Gibson FM, Bagnara M, Gordon-Smith EC, Rutherford TR.
    Stem Cells; 1994 Mar; 12(2):180-6. PubMed ID: 8199561
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation.
    Verdonck LF, Heesbeen EC, van Heugten HG, Staal GE, Rijksen G.
    Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 9. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
    Gidáli J, Fehér I, Kovács P.
    Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
    Guyotat D, Shi ZH, Campos L, Rabat M, Bonnier S, Poncelet P, Laurent JC, Fiere D.
    Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
    [Abstract] [Full Text] [Related]

  • 12. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N, Mohamed R.
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [Abstract] [Full Text] [Related]

  • 13. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
    Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL.
    J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
    [Abstract] [Full Text] [Related]

  • 14. The role of methylcellulose on colony growth of human myeloid leukemic progenitors (AML-CFU).
    Allieri MA, Douay L, Deloux J, Smadja N, Najman A, Gorin NC.
    Exp Hematol; 1990 Sep; 18(8):911-5. PubMed ID: 2387341
    [Abstract] [Full Text] [Related]

  • 15. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
    Vogler WR, Olson AC, Berdel WE, Okamoto S, Glasser L.
    Prog Clin Biol Res; 1990 Sep; 333():1-18; discussion 19-20. PubMed ID: 2308973
    [Abstract] [Full Text] [Related]

  • 16. Alpha-interferon broadens the difference between surviving fractions of normal and leukemic progenitor cells in vitro by heat: its application to marrow purging.
    Moriyama Y, Goto T, Nikkuni K, Aoki A, Furukawa T, Narita M, Koyama S, Kishi K, Takahashi M, Shibata A.
    Bone Marrow Transplant; 1991 Oct; 8(4):301-5. PubMed ID: 1756327
    [Abstract] [Full Text] [Related]

  • 17. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D, Strife A, Atzpodien J, Clarkson BD.
    Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231
    [Abstract] [Full Text] [Related]

  • 18. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H, Bruecher J, Claudé R, Hoelzer D.
    Bone Marrow Transplant; 1993 Nov 15; 12(5):495-9. PubMed ID: 8298560
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.